心的外傷後ストレス障害（PTSD）治療薬の世界市場（～2026年）

• 英文タイトル：Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04335
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は心的外傷後ストレス障害（PTSD）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、抗不安薬）市場規模、用途別（病院、薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別心的外傷後ストレス障害（PTSD）治療薬の競争状況、市場シェア
・世界の心的外傷後ストレス障害（PTSD）治療薬市場：種類別市場規模 2015年-2020年（抗うつ薬、抗不安薬）
・世界の心的外傷後ストレス障害（PTSD）治療薬市場：種類別市場規模予測 2021年-2026年（抗うつ薬、抗不安薬）
・世界の心的外傷後ストレス障害（PTSD）治療薬市場：用途別市場規模 2015年-2020年（病院、薬局、その他）
・世界の心的外傷後ストレス障害（PTSD）治療薬市場：用途別市場規模予測 2021年-2026年（病院、薬局、その他）
・北米の心的外傷後ストレス障害（PTSD）治療薬市場分析：米国、カナダ
・ヨーロッパの心的外傷後ストレス障害（PTSD）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの心的外傷後ストレス障害（PTSD）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の心的外傷後ストレス障害（PTSD）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの心的外傷後ストレス障害（PTSD）治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：GlaxoSmithKline、Pfizer、Eli Lilly、H. Lundbeck
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD.
The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market.

Market Analysis and Insights: Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market
The global Post-Traumatic Stress Disorder (PTSD) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Scope and Market Size
Post-Traumatic Stress Disorder (PTSD) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
Pfizer
Eli Lilly
H. Lundbeck
…

Market segment by Type, the product can be split into
Antidepressants
Anxiolytics
Market segment by Application, split into
Hospital
Pharmacy
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antidepressants
1.4.3 Anxiolytics
1.5 Market by Application
1.5.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Perspective (2015-2026)
2.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Growth Trends by Regions
2.2.1 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Post-Traumatic Stress Disorder (PTSD) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Market Size
3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Concentration Ratio
3.2.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue in 2019
3.3 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players Head office and Area Served
3.4 Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Solution and Service
3.5 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)
5.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2015-2020)
6.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players in North America (2019-2020)
6.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020)
6.4 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2015-2020)
7.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2015-2020)
8.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players in China (2019-2020)
8.3 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020)
8.4 China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2015-2020)
9.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2015-2020)
10.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2015-2020)
11.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players in India (2019-2020)
11.3 India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020)
11.4 India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2015-2020)
12.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
13.1.4 GlaxoSmithKline Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
13.2.4 Pfizer Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
13.3.4 Eli Lilly Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 H. Lundbeck
13.4.1 H. Lundbeck Company Details
13.4.2 H. Lundbeck Business Overview
13.4.3 H. Lundbeck Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
13.4.4 H. Lundbeck Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020)
13.4.5 H. Lundbeck Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue
Table 3. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antidepressants
Table 6. Key Players of Anxiolytics
Table 7. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Post-Traumatic Stress Disorder (PTSD) Therapeutics Players
Table 18. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics as of 2019)
Table 21. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Solution and Service
Table 24. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share (2019-2020)
Table 34. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2015-2020)
Table 36. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share (2019-2020)
Table 40. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share (2019-2020)
Table 46. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2015-2020)
Table 48. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share (2019-2020)
Table 52. Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share (2019-2020)
Table 64. India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2015-2020)
Table 66. India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share (2019-2020)
Table 70. Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Product
Table 87. Eli Lilly Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020) (Million US$)
Table 88. Eli Lilly Recent Development
Table 89. H. Lundbeck Company Details
Table 90. H. Lundbeck Business Overview
Table 91. H. Lundbeck Product
Table 92. H. Lundbeck Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2015-2020) (Million US$)
Table 93. H. Lundbeck Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antidepressants Features
Figure 3. Anxiolytics Features
Figure 4. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Other Case Studies
Figure 8. Post-Traumatic Stress Disorder (PTSD) Therapeutics Report Years Considered
Figure 9. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Players in 2019
Figure 14. Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue in 2019
Figure 16. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

女性用性的欲求低下障害（HSDD）治療薬の世界市場（～2026年）

Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11926 2020年11月25日 98Pages
当調査資料は女性用性的欲求低下障害（HSDD）治療薬のグローバル市場について調査・分析したレポートです。種類別（BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他）市場規模、用途別（外来患者、入院患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

注意欠陥・多動性障害（ADHD）治療薬の世界市場（～2026年）

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY10921 2020年11月25日 91Pages
当調査資料は注意欠陥・多動性障害（ADHD）治療薬のグローバル市場について調査・分析したレポートです。種類別（覚醒剤、非覚醒剤）市場規模、用途別（専門クリニック、病院薬局、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

外傷性脳損傷治療の世界市場（～2026年）

Global Traumatic Brain Injuries Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04898 2020年11月20日 99Pages
当調査資料は外傷性脳損傷治療のグローバル市場について調査・分析したレポートです。種類別（手術、薬）市場規模、用途別（病院、神経内科医センター、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...

睡眠障害治療薬の世界市場（～2026年）

Global Sleep Disorder Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04641 2020年11月20日 96Pages
当調査資料は睡眠障害治療薬のグローバル市場について調査・分析したレポートです。種類別（不眠症、過度睡眠、睡眠障害）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

mRNA癌ワクチン・治療薬の世界市場（～2026年）

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY03858 2020年11月20日 92Pages
当調査資料はmRNA癌ワクチン・治療薬のグローバル市場について調査・分析したレポートです。種類別（腺癌、粘液性癌、腺扁平上皮癌）市場規模、用途別（感染症、がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

肝性脳症（HE）治療薬の世界市場（～2026年）

Global Hepatic Encephalopathy (HE) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12162 2020年11月25日 97Pages
当調査資料は肝性脳症（HE）治療薬のグローバル市場について調査・分析したレポートです。種類別（ラクツロース、リファキシミン、ネオマイシン、プロバイオティクス、チアミン）市場規模、用途別（急性肝不全、肝硬変）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

サイトメガロウイルス（CMV）治療薬の世界市場（～2026年）

Global Cytomegalovirus Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11556 2020年11月25日 98Pages
当調査資料はサイトメガロウイルス（CMV）治療薬のグローバル市場について調査・分析したレポートです。種類別（ガンシクロビル/バルガンシクロビル、ホスカルネット、シドフォビル）市場規模、用途別（CMV網膜炎、肺炎、胃腸潰瘍、脳炎、口内潰瘍、咽頭炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイ...

胃食道逆流症（GERD）治療薬の世界市場（～2026年）

Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12006 2020年11月25日 98Pages
当調査資料は胃食道逆流症（GERD）治療薬のグローバル市場について調査・分析したレポートです。種類別（制酸剤、運動促進薬、H2受容体遮断薬、プロトンポンプ阻害薬（PPI））市場規模、用途別（胸やけ、酸逆流症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

基底細胞がん（BCC）治療薬の世界市場（～2026年）

Global Basal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11023 2020年11月25日 91Pages
当調査資料は基底細胞がん（BCC）治療薬のグローバル市場について調査・分析したレポートです。種類別（手術、放射線療法、光線力学療法、薬物）市場規模、用途別（小売薬局、病院薬局、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

慢性リンパ性白血病（CLL）治療薬の世界市場（～2026年）

Global Chronic Lymphocytic Leukemia Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11368 2020年11月25日 98Pages
当調査資料は慢性リンパ性白血病（CLL）治療薬のグローバル市場について調査・分析したレポートです。種類別（注射式、経口式）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

外傷性脳損傷治療の世界市場（～2026年） Traumatic brain injury usually results from a violent blow or jolt to the head or body. Market Analysis and Insights: Global Traumatic Brain Injuries Treatment Market The global Traumatic Brain Injuries Treatment market size is projected to reach US$ 2178.1 million by 2026, from US$ 2112.1 million i…
睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …
女性用性的欲求低下障害（HSDD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Female …
注意欠陥・多動性障害（ADHD）治療薬の世界市場（～2026年） ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. G…
慢性外傷性脳症（CTE）の世界市場（～2026年） Chronic traumatic encephalopathy (CTE) is a kind of degenerative brain disease that is found in athletes, military veterans, and others with a history of repetitive brain trauma. Market Analysis and Insights: Global Chronic Traumatic Encephalopathy (CTE) Market The global Chronic Traumatic Encephalo…